Aditxt, Inc. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Aditxt, Inc. stock issued during period, value, issued for services for the quarter ending 2023-12-31 was $316.23K.
- Aditxt, Inc. stock issued during period, value, issued for services for the quarter ending 2023-09-30 was $0.00.
- Aditxt, Inc. stock issued during period, value, issued for services for the quarter ending 2023-06-30 was $0.00, a 100.00% decline year-over-year.
- Aditxt, Inc. stock issued during period, value, issued for services for the quarter ending 2023-03-31 was $168.30K, a 4425.41% increase year-over-year.
- Aditxt, Inc. stock issued during period, value, issued for services for fiscal 2023 was $484.52K, a 4.54% decline from fiscal 2022.
- Aditxt, Inc. stock issued during period, value, issued for services for fiscal 2022 was $507.56K, a 51.01% increase from fiscal 2021.
- Aditxt, Inc. stock issued during period, value, issued for services for fiscal 2021 was $336.12K, a 86.43% decline from fiscal 2020.
- Aditxt, Inc. stock issued during period, value, issued for services for fiscal 2020 was $2.48M, a 2921.26% increase from fiscal 2019.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2023-12-31 | $316.23K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $484.52K 10-K · filed 2025-03-31 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-18 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-19 | |
| 2023-03-31 | $168.30K 10-Q · filed 2024-11-18 | |
| 2022-12-31 | $507.56K 10-K · filed 2024-04-16 | |
| 2022-06-30 | $250.00K 10-Q · filed 2023-11-14 | |
| 2022-03-31 | $3.72K 10-Q · filed 2023-11-14 | |
| 2021-12-31 | $336.12K 10-K · filed 2022-03-31 | |
| 2021-09-30 | $5.16K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $181.86K 10-Q · filed 2022-11-14 | |
| 2021-03-31 | $51.24K 10-Q · filed 2022-11-14 | |
| 2020-12-31 | $2.48M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $810.74K 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $83.19K 10-Q · filed 2021-11-15 | |
| 2020-03-31 | $419.00K 10-Q · filed 2021-11-15 | |
| 2019-12-31 | $82.00K 10-K · filed 2021-03-25 | |
| 2019-06-30 | $30.00K 10-Q · filed 2020-11-13 | |
| 2019-03-31 | $52.00K 10-Q · filed 2020-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |